share_log

Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $10

Moomoo 24/7 ·  Apr 1 05:42

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and lowers the price target from $11.5 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment